215 related articles for article (PubMed ID: 12771040)
21. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
Won YK; Ong CN; Shi X; Shen HM
Carcinogenesis; 2004 Aug; 25(8):1449-58. PubMed ID: 15033901
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors.
Pentland AP; Scott G; VanBuskirk J; Tanck C; LaRossa G; Brouxhon S
Cancer Res; 2004 Aug; 64(16):5587-91. PubMed ID: 15313895
[TBL] [Abstract][Full Text] [Related]
23. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.
Takigawa M; Verma AK; Simsiman RC; Boutwell RK
Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752
[TBL] [Abstract][Full Text] [Related]
25. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
26. Oral feeding of pomegranate fruit extract inhibits early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis.
Afaq F; Khan N; Syed DN; Mukhtar H
Photochem Photobiol; 2010; 86(6):1318-26. PubMed ID: 20946358
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
[TBL] [Abstract][Full Text] [Related]
29. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor.
Liang L; Hu D; Liu W; Williams JP; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S114-21. PubMed ID: 12902868
[TBL] [Abstract][Full Text] [Related]
30. Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection.
Tripp CS; Blomme EA; Chinn KS; Hardy MM; LaCelle P; Pentland AP
J Invest Dermatol; 2003 Oct; 121(4):853-61. PubMed ID: 14632205
[TBL] [Abstract][Full Text] [Related]
31. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?
Choy H; Milas L
J Natl Cancer Inst; 2003 Oct; 95(19):1440-52. PubMed ID: 14519750
[TBL] [Abstract][Full Text] [Related]
32. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of silymarin against photocarcinogenesis in a mouse skin model.
Katiyar SK; Korman NJ; Mukhtar H; Agarwal R
J Natl Cancer Inst; 1997 Apr; 89(8):556-66. PubMed ID: 9106644
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss.
Wheeler DL; Ness KJ; Oberley TD; Verma AK
Cancer Res; 2003 Jun; 63(12):3037-42. PubMed ID: 12810623
[TBL] [Abstract][Full Text] [Related]
35. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.
Wilgus TA; Ross MS; Parrett ML; Oberyszyn TM
Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):367-84. PubMed ID: 11060900
[TBL] [Abstract][Full Text] [Related]
36. Polyamines regulate expression of the neoplastic phenotype in mouse skin.
Peralta Soler A; Gilliard G; Megosh L; George K; O'Brien TG
Cancer Res; 1998 Apr; 58(8):1654-9. PubMed ID: 9563478
[TBL] [Abstract][Full Text] [Related]
37. Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors.
Wilgus TA; Breza TS; Tober KL; Oberyszyn TM
J Invest Dermatol; 2004 Jun; 122(6):1488-94. PubMed ID: 15175041
[TBL] [Abstract][Full Text] [Related]
38. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.
Love RR; Carbone PP; Verma AK; Gilmore D; Carey P; Tutsch KD; Pomplun M; Wilding G
J Natl Cancer Inst; 1993 May; 85(9):732-7. PubMed ID: 8478959
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.
Bailey HH; Kim K; Verma AK; Sielaff K; Larson PO; Snow S; Lenaghan T; Viner JL; Douglas J; Dreckschmidt NE; Hamielec M; Pomplun M; Sharata HH; Puchalsky D; Berg ER; Havighurst TC; Carbone PP
Cancer Prev Res (Phila); 2010 Jan; 3(1):35-47. PubMed ID: 20051371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]